Navigation Links
Epi-Peel® Glycolic Peel System

ProductsEpi-Peel® Glycolic Peel System
Company Dermatologic Cosmetic Laboratories
Item Epi-Peel® Glycolic Peel System
Features 
  • Willowherb Extract, at a clinically active level, helps soothe and calm the skin while the beneficial effects of the 40% active glycolic peel are taking effect.
  • Controlled dose, concentration and timing provide reproducible & predictable results each and every time.
  • Easy 3-step system makes procedure more efficient than ever before.
  • Advanced level 1 (40% active) gel formulation provides easier, more even application.
  • Available in 2 levels: level 1 (40% active) with willowherb extract. level 2 (70% active) includes the most effective topical anti-oxidant, Vitamin C, in a highly stable water soluble form- magnesium ascorbyl phosphate. The addition of this ingredient helps even skin tone and maximize efficacy of the glycolic peel.
Description The Epi-Peel® System is available in two innovative formulations: Level 1 (40% active) and Level II (70% active). The Level I (40% active) formulation introduces a clinically active level of willowherb extract, which DCL scientists have identified and incorporated into the formula to help soothe and calm the skin while the beneficial effects of the peel are taking effect. The formula is also a gel-like consistency designed for easier spreadability and even application. The Level II (70% active) formulation includes the most effective topical anti-oxidant, Vitamin C, in a highly stable water soluble form- magnesium ascorbyl phosphate. The addition of this ingredient helps even skin tone and maximize efficacy of the glycolic peel.
Info Dermatologic Cosmetic Laboratories
Customer Service: 203-467-1570
Web site: http://www.dclskincare.com/

Related medicine products :

1. Glycolic Peels (Medical)
2. Glycolic Acid Peel
3. Silicone Oil Cannula System - 20 Gauge
4. Silicone Oil Cannula System - 19 Gauge
5. SuperVu Galilean System
6. KOWA nonmyd 7 / VK-2 Digital Imaging System
7. KOWA nonmyd a-D / VK-2 Digital Imaging System
8. Refraction System RT-2100
9. Odyssey Phacoemulsification System
10. SIStem Phacoemulsification System
11. Precisionist Phacoemulsification System
Our Reticulocyte Stain is a specialized hematology stain for identifying immature erythrocytes. These immature erythrocytes stain blue in a fine mesh network within the erythrocyte. Mature erythrocyt...
... Stain is a single solution ... buffer, and stain for rapid ... smears. It is packaged in ... of use and is suitable ...
This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast....
Medicine Products:
(Date:5/6/2016)... , ... May 06, 2016 , ... Canadian author Mark Black is a ... Life From the Heart" around the world … with the help of his publisher Strategic ... 24, Mark Black lay in a hospital bed waiting for a miracle: He needed a ...
(Date:5/6/2016)... ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... he has found in the Bible about helping to stop cancer. Yisrayl says there are ... his hope that the health and science industries will pay close attention and take action. ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... David Konur, CEO of Cardiovascular Institute of the South announced today that Dr. ... a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. , ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and profession ... the impact our aging population has on communities and resources. Aging Life Care plays ... and face age-related challenges. , Aging Life Care is a holistic, client-centered approach ...
(Date:5/5/2016)... ... May 05, 2016 , ... The U.S. Food and ... e-cigarette manufacturers to submit their products through an arduous federal approval process. The ... that entered the market since February 15, 2007. That would essentially ban 99 ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute Myeloid Leukemia Market and ... their offering.       (Logo: ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Myeloid Leukemia epidemiology, Acute ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
Breaking Medicine Technology: